BD BBL™ Fluid Thioglycollate Medium 221196Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ Fluid Thioglycollate Medium, 8 mL, Carton of 100 size K tubes · Class 1
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 30382902211960), received between Jul 15, 2022 and Jan 2, 2024 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Apr 24, 2025Open, Classified
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Z-1828-2025 · Root cause: Storage · FDA record ↗
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings2
- Contamination /Decontamination Problem1
- Contamination of Device Ingredient or Reagent1
- Particulates1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 2, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHEN USING THE BD BBL¿ FLUID THIOGLYCOLLATE MEDIUM HAD NOTICED A GROWTH IN THE TUBE AFTER INOCULATION. THERE WAS NO REPORT OF IMPACT TO PATIENT OR USER.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18428520 ↗MalfunctionMar 20, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT WHILE USING THE BD BBL¿ FLUID THIOGLYCOLLATE MEDIUM THAT THERE WAS CONTAMINATION GROWTH ON THE PLATE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTS THAT THEY HAD GROWTH IN A NEGATIVE CONTROL IN 221196.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16575530 ↗MalfunctionMar 8, 2023Particulates; Contamination /Decontamination Problem
IT WAS REPORTED THAT WHILE USING THE BD BBL¿ FLUID THIOGLYCOLLATE MEDIUM THAT THERE WAS CONTAMINATION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER REPORTS: AS PART OF OUR ACCEPTANCE PROCEDURES WE INCUBATE SEVERAL TUBES IMMEDIATELY ON RECEPTION AS A NEGATIVE CONTROL BEFORE GROWTH PROMOTION IS COMPLETED. ONE OF THE FTM TUBES THAT WE INCUBATED CAME BACK POSITIVE DESPITE BEING A NEGATIVE CONTROL AND WE FOUND PARTICULATES FLOATING IN THE MEDIA OF 2 OTHER TUBES. LOT 2312524.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16504519 ↗MalfunctionJul 15, 2022Contamination of Device Ingredient or Reagent; Contamination of Device Ingredient or Reagent
IT WAS REPORTED WHILE USING THE BD BBL¿ FLUID THIOGLYCOLLATE MEDIUM THAT THERE WAS CONTAMINATED TUBED MEDIA. THE CUSTOMER REPORTED THAT THIS OCCURRED 400 TIMES. SUBJECT LINE SHOULD READ: MEDIA 221196 CONTAMINATED TUBED MEDIA CUSTOMER REPORTS CONTAMINATED TUBED MEDIA- LOT #1349733.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15029229 ↗
Other CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL devices
- BD BBL™ Enriched Thioglycollate Medium 221788Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL160 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood and MacConkey II Agar I Plate™ 221291Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL106 reports
- BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood (TSA II) 221261Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL1 recall51 reports
- BD BBL™ CDC Anaerobe 5% Sheep Blood Agar 221734Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL63 reports
- BD BBL™ Trypticase™ Soy Broth 221716Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL31 reports
- BD BBL™ Trypticase™ Soy Broth 297354Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL27 reports
- BD BBL™ Trypticase™ Soy Agar (Soybean-Casein Digest Agar) 221283Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL19 reports
- BD BBL™ Enriched Thioglycollate Medium 221742Becton, Dickinson And Company · CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL18 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.